A detailed history of Laurion Capital Management LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 6,155 shares of VKTX stock, worth $441,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,155
Holding current value
$441,621
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $291,685 - $493,631
6,155 New
6,155 $326,000
Q2 2023

Aug 14, 2023

SELL
$14.84 - $24.79 $22.9 Million - $38.3 Million
-1,546,076 Reduced 91.09%
151,276 $2.45 Million
Q1 2023

May 15, 2023

BUY
$8.08 - $17.33 $3.22 Million - $6.9 Million
398,352 Added 30.67%
1,697,352 $28.3 Million
Q3 2022

Nov 14, 2022

SELL
$2.55 - $3.89 $63,262 - $96,507
-24,809 Reduced 1.87%
1,299,000 $3.53 Million
Q2 2022

Aug 15, 2022

BUY
$2.11 - $3.15 $2.79 Million - $4.17 Million
1,323,809 New
1,323,809 $3.83 Million
Q2 2018

Aug 13, 2018

SELL
$3.88 - $12.74 $193,945 - $636,821
-49,986 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$4.11 - $6.93 $205,442 - $346,402
49,986 New
49,986 $218,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.5B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.